Article

Molecular profiling in lung cancer

2022-07-19

Abstract excerpt

Summary The biology of non-small cell lung cancer (NSCLC) is driven by a complex mutational landscape, and the detection of driver molecular alterations by next-generation sequencing is key for identification of druggable alterations. Thus, broad molecular profiling displays a standard-of-care approach particularly in patients with advanced adenocarcinoma at the time of the initial diagnosis, but also at the time...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 99954537-38ff-5771-92a3-9584b771fe40
DOI: 10.1007/s12254-022-00824-7

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular profiling in lung cancerDOI 10.1007/s12254-022-00824-7Read

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.Semantic proximity Read

Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer.Semantic proximity Read

The evolving paradigm of precision medicine in lung cancer.Semantic proximity Read

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.Semantic proximity Read

Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions.Semantic proximity Read

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read

Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?Semantic proximity Read

Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung CancerSemantic proximity Read

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.Semantic proximity Read

Next-Generation Sequencing for Lung CancerSemantic proximity Read

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.Semantic proximity Read